EcoDrugPlus

Janus Kinase 2

Ensembl ID : ENSCVAG00000000414
Gene Symbol: JAK2
3 Cross references
194 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSCVAG00000006062
Gene Symbol: KRAS
3 Cross references
208 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSCVAG00000015732
Gene Symbol: MALT1
2 Cross references
198 Possible Orthologues:

Map7 Domain-Containing Protein 1-Like

Ensembl ID : ENSCVAG00000001553
Gene Symbol: LOC107102681
2 Cross references
136 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSCVAG00000005043
Gene Symbol: MAPKAPK2
3 Cross references
186 Possible Orthologues:

Mapk Activated Protein Kinase 5

Ensembl ID : ENSCVAG00000020257
Gene Symbol: MAPKAPK5
3 Cross references
179 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSCVAG00000010870
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSCVAG00000006751
Gene Symbol: MDM2
3 Cross references
282 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSCVAG00000008825
Gene Symbol: MET
3 Cross references
204 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSCVAG00000021325
Gene Symbol: MLST8
3 Cross references
186 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSCVAG00000004405
Gene Symbol: NPC1L1
4 Cross references
190 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSCVAG00000020514
Gene Symbol: LOC107085666
3 Cross references
194 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).